Metrics as of 10/17/2026, 08:46 AM (Berlin time), refresh in progress.
Alcon Stock
Alcon Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Country
- Switzerland
- CEO
- David J. Endicott
- Employees
- 25,000
- Market cap
- $32 B
- IPO
- 09/04/2019
Alcon Inc. is a healthcare company based in Geneva, Switzerland. Founded in 1945, the company researches, develops, manufactures, distributes, and sells eye care products worldwide. The business operates through two segments, Surgical and Vision Care. Within the Surgical segment, the company offers equipment,…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Alcon stock: price history
1D
-0.6%
1W
+3.2%
1M
-0.2%
6M
-18.6%
YTD
-16.0%
1Y
-12.2%
2Y
-30.5%
5Y
-15.2%
10Y
–
Next earnings date
Next earnings date
10/11/2026 (in 24 days)
Volatility around earnings
~82% stronger price swings than usual
Alcon stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about Alcon
Analyst assessment of Alcon
PRICE TARGET LOW
US$35.00
CONSENSUS
US$72.88
MEDIAN
US$76.50
PRICE TARGET HIGH
US$85.00
0
STRONG BUY
14
BUY
10
HOLD
2
SELL
0
STRONG SELL
26
TOTAL · Buy
As of: 12/10/2026
Alcon stock metrics
P/E
50.91
P/B
1.49
EV/EBITDA
12.98
RETURN ON EQUITY
0.0%
NET MARGIN
0.0%
DEBT/EQUITY
0.25
DIVIDEND YIELD
0.5%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.7%
FLOAT SHARES
481,833,784
AVG. DAILY VOLUME (30D)
1,804,914
Institutional holders
Dividends
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Alcon stock
What does Alcon do?
Alcon Inc. is a company in the Healthcare sector, Medical - Specialties industry, headquartered in Switzerland.
The CEO is David J. Endicott, the company employs around 25,000 people.
The IPO was on 09/04/2019; the stock trades on NYSE under the ticker ALC.
What do analysts say about Alcon stock?
26 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
The average price target is US$72.88, ranging from US$35.00 to US$85.00, with a median of US$76.50.
This is an external assessment, not a statement by Market Jury.
When does Alcon report next?
The next earnings date is 10/11/2026.
Around past earnings, price swings were roughly 82% stronger than usual.
Does Alcon pay a dividend?
Yes. The last dividend was US$0.36 per share, ex-date 06/05/2026, paid on 07/05/2026.
The dividend yield is 0.5% (as of 30/06/2026).
Which stocks are comparable to Alcon?
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Roche Holding, BeOne Medicines and Sandoz Group.
How can I get Alcon stock analyzed?
Clicking "Analyze stock" lets five strategies assess Alcon against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.